Skip to content
← Back to this collection

PUBLICATIONS · 32271897

Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2020 Apr 14
First author
Lévy R

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood Adv. 2023 Mar 14;7(5):800. doi: 10.1182/bloodadvances.2022008500.
    note
    Source null
    related pmid
    36867456
    relationship
    Erratum in

Authors and identifiers

  1. name
    Lévy R
    type
    Author
  2. name
    Fusaro M
    type
    Author
  3. name
    Guerin F
    type
    Author
  4. name
    Chetouani A
    type
    Author
  5. name
    Moshous D
    type
    Author
  6. name
    Fischer A
    type
    Author
  7. name
    de Saint Basile G
    type
    Author
  8. name
    Sepulveda FE
    type
    Author
  9. name
    Neven B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lévy R
    type
    Author
  2. name
    Fusaro M
    type
    Author
  3. name
    Guerin F
    type
    Author
  4. name
    Chetouani A
    type
    Author
  5. name
    Moshous D
    type
    Author
  6. name
    Fischer A
    type
    Author
  7. name
    de Saint Basile G
    type
    Author
  8. name
    Sepulveda FE
    type
    Author
  9. name
    Neven B
    type
    Author
bibliography ids
  1. nci-bib-7e3f5cbcd819e7d9ecb3a607
book metadata
content sha256
e7cabcc2f991092981da339f776fff67c53d223c5e09108b27276b46e690720f
document type
citation
dois
  1. 10.1182/bloodadvances.2020001497
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32271897
immutable id
pubmed:32271897@e7cabcc2f991092981da339f776fff67c53d223c5e09108b27276b46e690720f
journal
abbreviation
Blood Adv
issn electronic
2473-9537
issn print
2473-9529
issue
7
name
Blood advances
nlm unique id
101698425
pages
1383-1387
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood Adv. 2023 Mar 14;7(5):800. doi: 10.1182/bloodadvances.2022008500.
    note
    Source null
    related pmid
    36867456
    relationship
    Erratum in
outcomes validated
false
pmid
32271897
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
6ea3c642f440280c9c896a89a70e72125e15627e1c9d4e2dff2d545ef823144f
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Apr 14
precision
day
year
2020
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32271897/
title
Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.

Preserved source evidence · Not medical advice